Entry |
|
Name |
Radium Ra 223 dichloride (USAN); Xofigo (TN) |
Product |
|
Formula |
RaCl2
|
Exact mass |
292.9562
|
Mol weight |
296.906
|
Structure |

|
Simcomp |
|
Remark |
Therapeutic category: | 4291 |
|
Efficacy |
Antineoplastic, Radioactive agent |
Disease |
Prostate cancer, castration-resistant [DS: H00024] |
Target |
DNA |
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
V VARIOUS
V10 THERAPEUTIC RADIOPHARMACEUTICALS
V10X OTHER THERAPEUTIC RADIOPHARMACEUTICALS
V10XX Various therapeutic radiopharmaceuticals
V10XX03 Radium (223Ra) dichloride
D10398 Radium Ra 223 dichloride (USAN) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
429 Miscellaneous
4291 Other Antitumors
D10398 Radium Ra 223 dichloride (USAN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10398
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10398
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10398
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10398
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 3
1 Z Ra 13.7900 -12.6700
2 X Cl 15.2824 -13.6500
3 X Cl 12.2976 -13.6500
BOND 2
1 1 2 1
2 1 3 1
|